Experimental evidence suggests that AMPK activation attenuates lipotoxicity, reactive oxygen species generation, inflammation, and endothelial dysfunction in type 2 diabetes [13–15]. The gene discussed is PRKAA1; the disease is type 2 diabetes mellitus.